Krishna Institute of Medical Sciences Limited

Krishna Institute of Medical Sciences Limited

Krishna Institute of Medical Sciences Limited has informed the Exchange about Certificate under regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming the acceptance and listing of dematerialized securities for the quarter ended 30th September 2026.

Krishna Institute of Medical Sciences Limited

Krishna Institute of Medical Sciences Limited has informed the Exchange about General Updates, correcting inadvertent typographical errors in financial metrics of target entities in a previous filing.

Krishna Institute of Medical Sciences Limited

Krishna Institute of Medical Sciences Limited has informed the Exchange about Acquisition of equity stake in Splendid Hospitals Private Limited (Kompally) by investing up to Rs. 40.00 Cr, by way of primary infusion.

Krishna Institute of Medical Sciences Limited

Krishna Institute of Medical Sciences Limited has informed the Exchange about the acquisition of 51% equity stake in Sarvottam Health Care Private Limited (Kakinada) for up to Rs. 80.00 Cr.

Krishna Institute of Medical Sciences Limited

Krishna Institute of Medical Sciences Limited has informed the Exchange about the acquisition of a 6% stake in Ushahkal Abhinav Specialty Hospital LLP (Sangli) for ₹15 Crore.

Krishna Institute of Medical Sciences Limited

Krishna Institute of Medical Sciences Limited has informed the Exchange about Acquisition of upto 51% equity stake in Insignia Healthcare Private Limited, an O & M entity.

Krishna Institute of Medical Sciences Limited

Krishna Institute of Medical Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, for the consideration of unaudited financial results for the 2nd quarter and half-year ending 30th September 2026.

Krishna Institute of Medical Sciences Limited

Krishna Institute of Medical Sciences Limited has informed the Exchange about the schedule of an Analyst/ Institutional Investor Meeting, to be held on September 22, 2026, at the Anand Rathi Annual Flagship Mumbai, Group Meeting Conference G-200 Summit 2026 India.

Krishna Institute of Medical Sciences Limited

Krishna Institute of Medical Sciences Limited has informed the Exchange about the schedule of an Analyst/Institutional Investor Meeting, to be held on September 21, 2026, at the J.P. Morgan India Conference in Mumbai.

Krishna Institute of Medical Sciences Limited

Krishna Institute of Medical Sciences Limited has entered into an Operations and Management Agreement with Sarvottam Health Care Private Limited for an initial term of 5 years with an extension for a further period of 5 years.

Krishna Institute of Medical Sciences Limited

Krishna Institute of Medical Sciences Limited has informed the Exchange about the schedule of an Analyst / Institutional Investor Meeting on September 10th, 2026, where officials will interact with Institutional Investors/Analysts.

Krishna Institute of Medical Sciences Limited

Krishna Institute of Medical Sciences Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 27, 2026, and informed the Exchange regarding voting results.

Krishna Institute of Medical Sciences Limited

Krishna Institute of Medical Sciences Limited held its 24th Annual General Meeting (AGM) on August 27, 2026, through video conferencing. The meeting was attended by 71 members, and the business mentioned in the Notice dated August 3, 2026, was transacted. The proceedings were recorded, and the e-voting system was provided by MUFG Intime India Private Limited.

Krishna Institute of Medical Sciences Limited

Krishna Institute of Medical Sciences Limited has clarified that a news report about acquiring a stake in Renova Hospitals for $52 million is false and baseless.

Krishna Institute of Medical Sciences Limited

Krishna Institute of Medical Sciences Limited has entered into an Operations and Management Agreement and Call Option Agreement with Aurevia Hospitals Private Limited for an initial term of 5 years to manage and operate Arete Hospitals in Hyderabad, Telangana.

Krishna Institute of Medical Sciences Limited

Krishna Institute of Medical Sciences Limited has informed the Exchange regarding allotment of 7702182 fully convertible warrants securities pursuant to Preferential Issue. The company has received Rs. 1,499,999,944.50 from the allottees for the warrant subscription, which is equivalent to 25% of the issue price of the said Warrants. The warrants shall be convertible into equity shares of the Company within a period of 18 months from the date of allotment of the Warrants.

Krishna Institute of Medical Sciences Limited

Krishna Institute of Medical Sciences Limited has announced its Q1 FY '27 earnings, with revenue of INR 1,196 crore, a growth of 36.1% year-on-year and 10.3% on quarter-on-quarter basis. EBITDA was INR 240 crore, with a growth of 20.1% year-on-year and 10.9% on quarter-on-quarter basis. PAT was INR 37 crores, with a growth of 11.8% year-on-year and a decline of 9.1% on quarter-on-quarter basis.

Krishna Institute of Medical Sciences Limited

Krishna Institute of Medical Sciences Limited has received in-principle approval from BSE and NSE for the issue and allotment of 77,02,182 warrants convertible into equity shares to promoters/promoter group on a preferential basis.

Krishna Institute of Medical Sciences Limited

Krishna Institute of Medical Sciences Limited

Krishna Institute of Medical Sciences Limited has dispatched a letter to members whose email addresses are not registered with the company, providing a web-link to the Annual Report for the Financial Year 2025-26 and informing them about the 24th Annual General Meeting scheduled on August 27, 2026.